Displaying drugs 14551 - 14575 of 14839 in total
Dioxo(sulfanyl)molybdenum
Experimental
BTA9881
BTA9881 is a respiratory syncytial virus (RSV) antiviral drug developed by the Australian company Biota Holdings. It is currently in phase I trials.
Investigational
SLx-4090
SLx-4090 is a microsomal triglyceride transfer protein (MTTP) inhibitor potentially for the treatment of type 2 diabetes.
Investigational
Dihydroxy(oxo)molybdenum(6+)
Experimental
Zanapezil
Zanapezil (TAK-147) is a selective acetylcholine (ACh) esterase inhibitor under investigation as a drug for Alzheimer's disease (AD) treatment.
Investigational
Thiopyrophosphate
Experimental
Dihydrogenphosphate
Experimental
Perchlorate
Experimental
VLTS-589
VLTS-589 consists of plasmid encoding the angiomatrix protein Del-1 in conjunction with poloxamer 188 for the treatment of peripheral vascular disease.
Investigational
99mTc-glucarate
99mTc-glucarate(GLA) is an agent for non-invasive detection of breast tumours.
Investigational
Duroquinone
Experimental
Cyclohexanone
Cyclohexanone (also known as oxocyclohexane, pimelic ketone, ketohexamethylene, cyclohexyl ketone or ketocyclohexane) is a six-carbon cyclic molecule with a ketone functional group. It is a colorless, oily liquid with an acetone-like smell.
Experimental
(Diphosphono)Aminophosphonic Acid
Experimental
Triphosphoric acid
Used as water softener, peptizing agent, emulsifier & dispersing agent; ingredient of cleansers; meat preservative.
Experimental
Hypophosphite
Experimental
Nitrate
Experimental
Investigational
Cyclo-Tetrametavanadate
Experimental
Crotonaldehyde
Experimental
PA-1050040
PA1050040, a second generation HIV-1 maturation inhibitor, is a chemical analog of Bevirimat (BVM). It inhibits virus replication by the same mechanism of action as BVM.
Investigational
Sulfuric acid
Experimental
4-hydroxybutan-2-one
Experimental
Monofluorophosphate ion
Experimental
Phosphate ion
Experimental
2-Undecanone
Experimental
Displaying drugs 14551 - 14575 of 14839 in total